Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) shares rose 21.2% on Friday . The stock traded as high as C$0.21 and last traded at C$0.20. Approximately 292,294 shares were traded during trading, a decline of 46% from the average daily volume of 538,273 shares. The stock had previously closed at C$0.17.
Voyageur Pharmaceuticals Stock Down 10.0 %
The company has a debt-to-equity ratio of 3.21, a current ratio of 0.17 and a quick ratio of 0.84. The stock’s fifty day simple moving average is C$0.11 and its 200-day simple moving average is C$0.08. The stock has a market cap of C$25.10 million, a P/E ratio of -18.00 and a beta of 0.32.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Featured Stories
- Five stocks we like better than Voyageur Pharmaceuticals
- Growth Stocks: What They Are, What They Are Not
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
- Business Services Stocks Investing
- Microsoft and Meta’s AI Investment Plans Are Full Steam Ahead
- How to Start Investing in Real Estate
- Beyond Self-Driving Cars: Factory Automation Takes Center Stage
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
